Grubb B P, Tilley-Gray B
Am J Med Sci. 1986 Sep;292(3):160-3. doi: 10.1097/00000441-198609000-00008.
Flecainide has been shown to be a relatively safe and effective antiarrhythmic agent. Its twice daily dosage schedule and demonstrated efficacy in suppression of ventricular ectopy suggest that it will be a valuable agent in the therapy of ventricular arrhythmias.